is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
2 January 2018
The Association of British Healthcare Industries (ABHI) is taking over 150 companies to Arab Health 2018. The UK’s leading MedTech association believes this strong contingency highlights a desire for British companies to forge deeper, more sustainable trading relationships as the country navigates its departure from the EU.
Arab Health 2018 offers a global platform for the world’s leading manufacturers, wholesalers and distributors to meet with the scientific community in the Middle East and subcontinent to discuss business and develop new partnerships.
Paul Benton, Managing Director of International at ABHI, said: “We are actively seeking new commercial options across the key global markets that we have identified. When we consider the substantial investment into public health from the Government of the UAE, and wider Middle East, opportunities for UK companies providing value-based healthcare solutions are significant. This strong delegation of companies shows that the UK is open for business and is keen to forge global healthcare links in the region. Arab Health is the best trade show to drive this and the UK pavilion promises to be a hub of activity.”
With the UK Government recently launching its Industrial Strategy, which provides a framework to boost UK productivity and earning power, the MedTech sector, and broader Life Sciences industry, has been identified as having a critical role in its success.
UK MedTech is now worth £17 billion to the economy, and as well as supporting the UK to export globally, ABHI are also keen to speak to international companies wanting to do business within the UK. ABHI’s international membership has been set up to make it more accessible for global companies wishing to partner with their British counterparts.